🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aim of this study is to assess how effective PF-00592379 is in ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-01
Trial ID
NCT00273416
Treatments Being Tested
The effect of multiple oral administration of two doses of CG5503 PR (prolo...
Status
Completed
Location
DE001 - Contract research organisation
Start Date
2003-03
Trial ID
NCT03951402
This dedicated T/QT study will investigate the effect of relacorilant on ca...
Status
Completed
Location
Single Site
Start Date
2021-01-22
Trial ID
NCT04795479
Treatments Being Tested
The main goal of this trial is to learn about the effect of Lu AG06474 on a...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2023-10-13
Trial ID
NCT06077786
Treatments Being Tested
This three-year randomized controlled trial investigated whether wrestling ...
Status
Completed
Location
Regional Boarding School (YBO)
Start Date
2018-05-01
Trial ID
NCT07632924
Treatments Being Tested
Stress (Takotsubo) cardiomyopathy (SC) is a peculiar form of acute, reversi...
Status
Terminated
Location
University of Missouri
Start Date
2009-08
Trial ID
NCT01048125
This study will determine the relative abuse potential of intact and chewed...
Status
Completed
Location
Lifetree Clinical Research
Start Date
2013-11
Trial ID
NCT01986283
Treatments Being Tested
We propose to use an inhaled allergen challenge model to explore the indivi...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05
Trial ID
NCT01128595
Treatments Being Tested
This study emphasizes on the influence of changes in systemic flow and syst...
Status
Completed
Location
University Hospital Ghent
Start Date
2011-07
Trial ID
NCT01424800
To investigate the effect of three single oral doses of BIA 9-1067 (25 mg, ...
Status
Completed
Location
BIAL - Portela & Cª - Human Pharmacology Unit (UFH)
Start Date
2009-01
Trial ID
NCT02169466
Treatments Being Tested